|Packaging||14ml in 1vial|
|Company Name||Perjeta 420mg injection|
|Generic Name||Pertuzumab injection|
Introduction of Perjeta 420 Mg Injection:
A drug called Perjeta 420 Mg Injection is used to treat breast cancer that is HER2-positive. Pertuzumab, a monoclonal antibody found in it, attaches to the HER2 receptor on the surface of cancer cells and stops those cells from growing and migrating.
Uses of Perjeta 420 Mg Injection:
HER2-positive metastatic breast cancer is treated with Perjeta in combination with other drugs like Herceptin and chemotherapy. In cases of early-stage, HER2-positive breast cancer, it is also used prior to surgery to reduce the size of the tumour.
Mechanism of action of Perjeta 420 Mg Injection:
The HER2 receptor on the surface of cancer cells is where Perjeta functions. By attaching to the receptor, Perjeta stops the receptor from activating and from transmitting signals that promote cell growth and division. Perjeta can sluggish or stop tumour growth by inhibiting the HER2 receptor.
Side effects of Perjeta 420 Mg Injection :
The most common side effects of Perjeta include:
Neutropenia (low white blood cell count)